Cita APA

Díez, J., & Bayes‐Genis, A. (2017). Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic. J Am Heart Assoc.

Citación estilo Chicago

Díez, Javier, y Antoni Bayes‐Genis. "Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic." J Am Heart Assoc 2017.

Cita MLA

Díez, Javier, y Antoni Bayes‐Genis. "Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic." J Am Heart Assoc 2017.